To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,057.002 days ago
1,070.002 days ago
arrow

LOWER/UPPER CIRCUITS

848.30
1,272.40
arrow
Novartis India Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : 10.47%
Novartis India Ltd Top mutual funds holding
arrow
Novartis India Limited is a pharmaceutical company. The business operations of the Company include Pharmaceuticals Generic over the counter (OTC) and Animal Health. The Pharmaceuticals segment consists of a portfolio of prescription medicines which are provided to patients through healthcare professionals. The Generics segment consists of retail generics products. The Generics segment’s unit primarily focuses on the therapeutic segments such as Anti-TB Anti-DUB (Gynaecology) Anti-histamines Antibiotics Anti-ulcerants Anti-diabetes and Cardiovascular. The Animal Health segment has a presence primarily in the cattle and poultry market segments. The OT C segment is mainly in the vitamins minerals and nutritional supplements (VMS) and cough cold and allergy (CoCoA) market segments. During the fiscal year ended March 31 2012 it introduced Enplus product in the Poultry segment and Dexbov Antifur Vayuhara Vetimam and Feedavit in the Cattle segment..The company also in the business activities of OTC Generics Animal Health Pharmaceuticals.
personal

Grow your wealth with more research recommendations

+91